Forte Biosciences Inc. (NASDAQ: FBRX)
$19.8550
+0.4150 ( -3.62% ) 35.9K
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
Market Data
Open
$19.8550
Previous close
$19.4400
Volume
35.9K
Market cap
$124.29M
Day range
$19.3000 - $22.8700
52 week range
$4.1100 - $28.6800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Aug 22, 2024 |
| 10-q | Quarterly Reports | 59 | Aug 14, 2024 |
| 8-k | 8K-related | 62 | Aug 14, 2024 |
| ars | Annual reports | 1 | Jul 30, 2024 |
| def | Proxies and info statements | 7 | Jul 30, 2024 |
| pre | Proxies and info statements | 6 | Jul 19, 2024 |
| 4 | Insider transactions | 1 | Jul 03, 2024 |
| 4 | Insider transactions | 1 | Jul 03, 2024 |
| 8-k | 8K-related | 16 | Jun 14, 2024 |
| 10-q | Quarterly Reports | 57 | May 13, 2024 |